Back to search

University of Glasgow

Investigating the cooperation of APC and KRAS mutations in colorectal cancer

Abstract

dc:description.abstract

Colorectal Cancer (CRC) progresses in a stepwise manner accumulating mutations in particular signalling pathways. Despite our knowledge of the genetic progression of the disease, the resulting phenotypes of the different mutation combinations remains poorly understood. I used genetically engineered mouse models to investigate the cooperation of two frequent early mutations - loss of the tumour suppressor gene APC and activating KRAS mutations, to try and identify potential therapeutic targets. Hyperactivated Wnt signalling is a hallmark of CRC, although efficacious therapies are limited. In chapter 3 I focussed on targeting this pathway at the level of β-catenin mediated transcription. I showed that deletion of BLC9 and BCL9l, two proteins involved in β-catenin mediated transcription, suppresses proliferation and the expression of a subset of Wnt target genes following loss of APC and KRAS activation. I showed that these two proteins are dispensable intestinal homeostasis. I also showed that deletion of BCL9 and BCL9l significantly accelerated tumour initiation. In chapter 4 I performed unbiased quantitative proteomics on crypt cultures from VillinCreER Apcfl/fl (APC) and VillinCreER Apcfl/fl KrasG12D/+ (APC KRAS) mice to identify deregulated signalling pathways between these two genotypes. I identified a ‘nutrient stress’ phenotype in APC KRAS crypts. I show that this might be driven by a significant increase in protein synthesis, since APC KRAS cells are trying to regulate their rates of protein synthesis via eIF2α signalling. In chapter 5 I investigated changes in the metabolomes between APC and APC KRAS cells. I show that APC KRAS crypt cultures are highly dependent on glutamine for growth and upregulate many genes involved in glycolysis and glutaminolysis. I show that APC KRAS cells are metabolically flexible and also highlight the role the environment plays in metabolic phenotypes. Overall, I have shown that intestinal epithelial cells with high-Wnt and high-MAPK signalling are sensitive to Wnt inhibition. I have also shown that these two signalling pathways cooperate to drive increased protein synthesis and deregulated metabolism to fuel proliferation.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gay, David Michael

Subjects

dc:subject × 3

Rights

Language dc:language
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Gay, David Michael. Investigating the cooperation of APC and KRAS mutations in colorectal cancer. PhD thesis, University of Glasgow, 2018. https://doi.org/10.5525/gla.thesis.9089